Pelamed Pharmaceuticals had EBIT of $367.77 million in 2018. In addition, Pelamed had interest expenses of $95.37 million and a corporate tax rate of 21%. a. What was Pelamed's 2018 net income? b. What was the total of Pelamed's 2018 net income plus interest payments? c. If Pelamed had no interest expenses, what would have been its 2018 net income? How does it compare to your answer in part (a)? d. What was the amount of Pelamed's interest tax shield in 2018? a. What was Pelamed's 2018 net income? The 2018 net income was $ million. (Round to two decimal places.) b. What was the total of Pelamed's 2018 net income plus interest payments? The total of Pelamed's 2018 net income plus interest payments was \$ million. (Round to two decimal places.) c. If Pelamed had no interest expenses, what would have been its 2018 net income? How does it compare to your answer in part (a)? The 2018 net income with no interest expense would be $ million. (Round to two decimal places.) The 2018 net income with no interest expense is \$ million higher than the 2018 net income with interest expense. (Round to two decimal places.) d. What was the amount of Pelamed's interest tax shield in 2018? Pelamed's interest tax shield in 2018 was $ million. (Round to two decimal places.)